Paris based Nanobiotix has always had a nanophysics approach to medicine - the ways they are applying it could be expanding soon

blonca9
Sep 4, 2024
1 min read

Founder and CEO Laurent Levy gives an update on the company's robust radiation oncology program, and describes two new areas of therapeutics that he believes nanophysics could have utility.

Recent Posts

See All

ASCO 2025: PharmaMar presented data showing that the combo of Zepzelca and Tecentriq significantly improved survival as first-line maintenance therapy for extensive-stage small cell lung cancer

ASCO 2025: France based Transgene presented data for its personalized cancer vaccine in the adjuvant setting for HPV- head and neck cancer

ASCO 2025: Candel Therapeutics CEO Paul Peter Tak describes phase 3 prostate cancer data from the company's off-the-shelf, adeno delivered, cancer immunotherapy

Paris based Nanobiotix has always had a nanophysics approach to medicine - the ways they are applying it could be expanding soon

Recent Posts

Join the BiotechTV mailing list

Follow BiotechTV

Sponsors

Sponsor Spotlight